Skip to content

Assessment of adherence to the guidelines for the management of Obesity in patients in the line for Surgery to Reduce the Stomach

Assessment of adherence to the guidelines for self-management of Obesity in patients in the waiting line for Bariatric Surgery in SUS: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-775y3d
Enrollment
Unknown
Registered
2018-02-07
Start date
2018-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Morbid, Adult, Bariátric Surgery

Interventions

Group intervention: the operationalization will be developed by a multidisciplinary team including nutritionist, psychologist, physiotherapist and physical educator for the period of 1 year. The inter
water, foods that are part of food groups, varieties, culinary uses, preparation suggestions and nutritional properties
how to choose, preserve and handle food correctly
aspects that influence the use of food
aspects of time and attention devoted to eating
information on food, advertising, discounts/promotion and information about the cost of food. 2) The approach of the practice of physical activity will be to incentive the participants to achieve 150
stipulate goals and encourage the regular practice of moderate physica
Behavioural
C18.654.726.500.700

Sponsors

Universidade Estadual Paulista `` Julio de Mesquita Filho´´ Faculdade de Ciências Farmacêuticas, Câmpus Araraquara
Lead Sponsor
Fundação Faculdade Regional de Medicina de São José do Rio Preto- FUNFARME / Hospital de Base
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with indications for bariatric surgery; aged between 18 and 65 years.

Exclusion criteria

Exclusion criteria: patients that are receiving care or guidance from other services for weight loss; history of alcohol or drug abuse; inflammatory cardiovascular disease in the active phase; chronic kidney disease; active cancer; severe cardiovascular disease; chronic obstructive pulmonary disease; systemic arterial hypertension that do not use medication for control; untreated thyroid disorders; severe functional limitations.

Design outcomes

Primary

MeasureTime frame
Decreased body weight, assessed by electronic weighing, based on a variation of at least 5% of body weight reduction in pre and post intervention measurements.

Secondary

MeasureTime frame
Improvement of biochemical indicators of lipid and carbohydrate metabolism, evaluated from a sample of venous blood collected by venipuncture in the antecubital vein, before and after 1 year of intervention.

Countries

Brazil

Contacts

Public ContactMayara Evangelista

Universidade Estadual Paulista `` Julio de Mesquita Filho´´ Faculdade de Ciências Farmacêuticas, Câmpus Araraquara

mayaramartinsnutri@gmail.com5517991510925

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 22, 2026